Loading...
  • nucleic
  • repeat infection following treatment can also occur as a result of re-infection or it could be a false positive diagnosis due to the detection of non-viable (dead) chlamydia nucleic acid that is still clearing after treatment. (biomedcentral.com)
  • reservoir
  • Evidence from animal studies suggests that chlamydiae may persist in the gastrointestinal tract (GI) and be a reservoir for reinfection of the genital tract. (asm.org)
  • However, if chlamydiae persist in the GI tract as a reservoir and this serves as a source for genital reinfection, then one must hypothesize that azithromycin (Az) treatment which clears the genital infection is not able to eliminate GI infection in all individuals. (asm.org)
  • azithromycin
  • In this review, we will discuss the latest treatment efficacy data for anogenital chlamydia infection, examine the evidence about why treatment efficacy may vary between azithromycin and doxycycline and identify areas where further research is needed. (biomedcentral.com)
  • To determine the effect of azithromycin on persistent chlamydial gut infection, C57BL/6 and BALB/c mice were infected orally and genitally and treated with azithromycin (Az) orally (20, 40, or 80 mg/kg of body weight), and the numbers of chlamydiae were determined from cervix and cecal tissues. (asm.org)
  • Guidelines
  • While chlamydia screening is recommended by U.S. guidelines for all sexually active women younger than age 26, there is no similar recommendation for men who have sex with women. (clinicaladvisor.com)
  • among
  • The chlamydia rate is highest among 20 to 24-year-olds (1,907 per 100,000), with the next highest rate among 15 to 19-year-olds (1,385 per 100,000). (mn.us)
  • The chlamydia rate among females (443 per 100,000) is more than twice the rate among males (193 per 100,000), a difference most likely due to more frequent screening among women. (mn.us)
  • Active
  • Active surveillance for gonorrhea and chlamydia involves cross-checking laboratory-reported cases against cases reported by clinicians. (mn.us)
  • lead
  • Given that treatment failure could lead to ongoing CT transmission and an increased risk of complications associated with chlamydia, including HIV transmission, [ 4 - 6 ] it is vital that we understand the mechanisms of treatment failure and have access to highly efficacious treatments. (biomedcentral.com)
  • Drs. Cohen, Powderly and Opal, three of the most-respected names in infectious disease medicine, lead a diverse team of international contributors to bring you the latest knowledge and best practices. (livrariacultura.com.br)
  • cases
  • In 2011, 16,898 chlamydia cases (319 per 100,000 population) were reported, representing a 9% increase from 2010 (Table 3). (mn.us)
  • Although blacks comprise approximately 5% of Minnesota's population, they account for 29% of reported chlamydia cases. (mn.us)
  • risk
  • For both genital chlamydia and LGV, treatment of sexual partners is recommended to reduce risk of reinfection in the original patient. (clinicaladvisor.com)
  • women
  • In addition, chlamydia screening in women has been added as a quality measure for insurance plans and managed care organizations. (clinicaladvisor.com)
  • Thus, we have proposed that chlamydiae can persist in the gastrointestinal tract and that women can be reinfected in the genital tract by autoinfection from the rectum. (asm.org)
  • increase
  • While there was an overall increase of 9% across the state in 2011 the greatest increase for chlamydia was seen in the suburban area (metropolitan area excluding Minneapolis and St. Paul) with an increase of 15%, shown in Table 4. (mn.us)